ReP USP - Resultado da busca

Artigo de periodico
Effects of a single dose of Ayahuasca in college students with harmful alcohol use: a Single-blind, feasibility, proof-of-concept trial (2024)
Rodrigues, Lucas Silva; Reis, José Augusto Silva; Rossi, Giordano Novak ; Guerra, Lorena Terene Lopes ; Maekawa, Renan Massanobu ; Osório, Flávia de Lima ; Bouso, José Carlos; Santos, Fabiana Pereira; Paranhos, Beatriz Aparecida Passos Bismara; Yonamine, Maurício ; Hallak, Jaime Eduardo Cecilio ; Santos, Rafael Guimarães dos
Fonte: Journal of Clinical Psychopharmacology. Unidades: FMRP, FCF
Assuntos: ALUCINOGÊNICOS, ENSAIO CLÍNICO, ÁLCOOL, ESTUDANTES UNIVERSITÁRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Lucas Silva et al. Effects of a single dose of Ayahuasca in college students with harmful alcohol use: a Single-blind, feasibility, proof-of-concept trial. Journal of Clinical Psychopharmacology, v. 44, p. 402-406, 2024Tradução . . Disponível em: https://dx.doi.org/10.1097/JCP.0000000000001872. Acesso em: 22 nov. 2025.
APA
Rodrigues, L. S., Reis, J. A. S., Rossi, G. N., Guerra, L. T. L., Maekawa, R. M., Osório, F. de L., et al. (2024). Effects of a single dose of Ayahuasca in college students with harmful alcohol use: a Single-blind, feasibility, proof-of-concept trial. Journal of Clinical Psychopharmacology, 44, 402-406. doi:10.1097/JCP.0000000000001872
NLM
Rodrigues LS, Reis JAS, Rossi GN, Guerra LTL, Maekawa RM, Osório F de L, Bouso JC, Santos FP, Paranhos BAPB, Yonamine M, Hallak JEC, Santos RG dos. Effects of a single dose of Ayahuasca in college students with harmful alcohol use: a Single-blind, feasibility, proof-of-concept trial [Internet]. Journal of Clinical Psychopharmacology. 2024 ; 44 402-406.[citado 2025 nov. 22 ] Available from: https://dx.doi.org/10.1097/JCP.0000000000001872
Vancouver
Rodrigues LS, Reis JAS, Rossi GN, Guerra LTL, Maekawa RM, Osório F de L, Bouso JC, Santos FP, Paranhos BAPB, Yonamine M, Hallak JEC, Santos RG dos. Effects of a single dose of Ayahuasca in college students with harmful alcohol use: a Single-blind, feasibility, proof-of-concept trial [Internet]. Journal of Clinical Psychopharmacology. 2024 ; 44 402-406.[citado 2025 nov. 22 ] Available from: https://dx.doi.org/10.1097/JCP.0000000000001872
Artigo de periodico
Interventions for deficits in recognition of emotions in facial expressions in major depressive disorder: an updated systematic review of clinical trials (2023)
Reis, José Augusto Silva; Rossi, Giordano Novak ; Osório, Flávia de Lima ; Bouso, José Carlos ; Hallak, Jaime Eduardo Cecilio ; Santos, Rafael Guimarães dos
Fonte: Neuroscience & Biobehavioral Reviews. Unidade: FMRP
Assuntos: DEPRESSÃO, COGNIÇÃO SOCIAL, EXPRESSÃO FACIAL, EMOÇÕES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REIS, José Augusto Silva et al. Interventions for deficits in recognition of emotions in facial expressions in major depressive disorder: an updated systematic review of clinical trials. Neuroscience & Biobehavioral Reviews, v. 153, p. 1-12, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.neubiorev.2023.105367. Acesso em: 22 nov. 2025.
APA
Reis, J. A. S., Rossi, G. N., Osório, F. de L., Bouso, J. C., Hallak, J. E. C., & Santos, R. G. dos. (2023). Interventions for deficits in recognition of emotions in facial expressions in major depressive disorder: an updated systematic review of clinical trials. Neuroscience & Biobehavioral Reviews, 153, 1-12. doi:10.1016/j.neubiorev.2023.105367
NLM
Reis JAS, Rossi GN, Osório F de L, Bouso JC, Hallak JEC, Santos RG dos. Interventions for deficits in recognition of emotions in facial expressions in major depressive disorder: an updated systematic review of clinical trials [Internet]. Neuroscience & Biobehavioral Reviews. 2023 ; 153 1-12.[citado 2025 nov. 22 ] Available from: https://doi.org/10.1016/j.neubiorev.2023.105367
Vancouver
Reis JAS, Rossi GN, Osório F de L, Bouso JC, Hallak JEC, Santos RG dos. Interventions for deficits in recognition of emotions in facial expressions in major depressive disorder: an updated systematic review of clinical trials [Internet]. Neuroscience & Biobehavioral Reviews. 2023 ; 153 1-12.[citado 2025 nov. 22 ] Available from: https://doi.org/10.1016/j.neubiorev.2023.105367
Artigo de periodico
Neostriatum neuronal TRPV1-signalling mediates striatal anandamide at high concentration facilitatory influence on neostriato-nigral dishinhibitory GABAergic connections (2023)
Silva, Juliana Almeida da ; Almada, Rafael Carvalho ; Falconi-Sobrinho, Luiz Luciano ; Pigatto, Glauce Regina; Hernandes, Paloma Molina; Coimbra, Norberto Cysne
Fonte: Brain Research Bulletin. Unidade: FMRP
Assuntos: ANTAGONISTAS, VIAS NEURAIS, MEDO, NEUROTRANSMISSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Juliana Almeida da et al. Neostriatum neuronal TRPV1-signalling mediates striatal anandamide at high concentration facilitatory influence on neostriato-nigral dishinhibitory GABAergic connections. Brain Research Bulletin, v. 192, p. 128-141, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.brainresbull.2022.11.014. Acesso em: 22 nov. 2025.
APA
Silva, J. A. da, Almada, R. C., Falconi-Sobrinho, L. L., Pigatto, G. R., Hernandes, P. M., & Coimbra, N. C. (2023). Neostriatum neuronal TRPV1-signalling mediates striatal anandamide at high concentration facilitatory influence on neostriato-nigral dishinhibitory GABAergic connections. Brain Research Bulletin, 192, 128-141. doi:10.1016/j.brainresbull.2022.11.014
NLM
Silva JA da, Almada RC, Falconi-Sobrinho LL, Pigatto GR, Hernandes PM, Coimbra NC. Neostriatum neuronal TRPV1-signalling mediates striatal anandamide at high concentration facilitatory influence on neostriato-nigral dishinhibitory GABAergic connections [Internet]. Brain Research Bulletin. 2023 ; 192 128-141.[citado 2025 nov. 22 ] Available from: https://doi.org/10.1016/j.brainresbull.2022.11.014
Vancouver
Silva JA da, Almada RC, Falconi-Sobrinho LL, Pigatto GR, Hernandes PM, Coimbra NC. Neostriatum neuronal TRPV1-signalling mediates striatal anandamide at high concentration facilitatory influence on neostriato-nigral dishinhibitory GABAergic connections [Internet]. Brain Research Bulletin. 2023 ; 192 128-141.[citado 2025 nov. 22 ] Available from: https://doi.org/10.1016/j.brainresbull.2022.11.014
Artigo de periodico
The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials (2023)
Rossi, Giordano Novak; Hallak, Jaime Eduardo Cecilio ; Baker, Glen; Dursun, Serdar M.; Santos, Rafael Guimarães dos
Fonte: European Archives of Psychiatry and Clinical Neuroscience. Unidade: FMRP
Assuntos: BIOMARCADORES, ANESTÉSICOS, ALUCINOGÊNICOS, DEPRESSÃO, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROSSI, Giordano Novak et al. The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials. European Archives of Psychiatry and Clinical Neuroscience, v. 273, n. 1, p. 129-155, 2023Tradução . . Disponível em: https://doi.org/10.1007/s00406-022-01460-2. Acesso em: 22 nov. 2025.
APA
Rossi, G. N., Hallak, J. E. C., Baker, G., Dursun, S. M., & Santos, R. G. dos. (2023). The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials. European Archives of Psychiatry and Clinical Neuroscience, 273( 1), 129-155. doi:10.1007/s00406-022-01460-2
NLM
Rossi GN, Hallak JEC, Baker G, Dursun SM, Santos RG dos. The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2023 ; 273( 1): 129-155.[citado 2025 nov. 22 ] Available from: https://doi.org/10.1007/s00406-022-01460-2
Vancouver
Rossi GN, Hallak JEC, Baker G, Dursun SM, Santos RG dos. The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2023 ; 273( 1): 129-155.[citado 2025 nov. 22 ] Available from: https://doi.org/10.1007/s00406-022-01460-2
Artigo de periodico-carta/editorial
Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach (2023)
Santos, Rafael Guimarães dos ; Rossi, Giordano Novak; Hallak, Jaime Eduardo Cecilio ; Öngür, Dost; Dursun, Serdar M.
Fonte: Current Neuropharmacology. Unidade: FMRP
Assuntos: ALUCINOGÊNICOS, ANTIDEPRESSIVOS, DEPRESSÃO, ANSIEDADE, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO, EDITORIAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Rafael Guimarães dos et al. Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach. Current Neuropharmacology. Sharjah: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.2174/1570159X20666220425133824. Acesso em: 22 nov. 2025. , 2023
APA
Santos, R. G. dos, Rossi, G. N., Hallak, J. E. C., Öngür, D., & Dursun, S. M. (2023). Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach. Current Neuropharmacology. Sharjah: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.2174/1570159X20666220425133824
NLM
Santos RG dos, Rossi GN, Hallak JEC, Öngür D, Dursun SM. Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach [Internet]. Current Neuropharmacology. 2023 ; 21( 1): 10-12.[citado 2025 nov. 22 ] Available from: https://doi.org/10.2174/1570159X20666220425133824
Vancouver
Santos RG dos, Rossi GN, Hallak JEC, Öngür D, Dursun SM. Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach [Internet]. Current Neuropharmacology. 2023 ; 21( 1): 10-12.[citado 2025 nov. 22 ] Available from: https://doi.org/10.2174/1570159X20666220425133824
Artigo de periodico
Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges (2022)
Rossi, Giordano Novak; Hallak, Jaime Eduardo Cecilio ; Saiz, José Carlos Bouso; Santos, Rafael Guimarães dos
Fonte: Expert Opinion on Drug Safety. Unidade: FMRP
Assuntos: ANTIDEPRESSIVOS, FÁRMACOS PSICOTRÓPICOS, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROSSI, Giordano Novak et al. Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges. Expert Opinion on Drug Safety, v. 21, n. 6, p. 761-776, 2022Tradução . . Disponível em: https://doi.org/10.1080/14740338.2022.2066650. Acesso em: 22 nov. 2025.
APA
Rossi, G. N., Hallak, J. E. C., Saiz, J. C. B., & Santos, R. G. dos. (2022). Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges. Expert Opinion on Drug Safety, 21( 6), 761-776. doi:10.1080/14740338.2022.2066650
NLM
Rossi GN, Hallak JEC, Saiz JCB, Santos RG dos. Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges [Internet]. Expert Opinion on Drug Safety. 2022 ; 21( 6): 761-776.[citado 2025 nov. 22 ] Available from: https://doi.org/10.1080/14740338.2022.2066650
Vancouver
Rossi GN, Hallak JEC, Saiz JCB, Santos RG dos. Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges [Internet]. Expert Opinion on Drug Safety. 2022 ; 21( 6): 761-776.[citado 2025 nov. 22 ] Available from: https://doi.org/10.1080/14740338.2022.2066650
Artigo de periodico
The adverse events of ibogaine in humans: an updated systematic review of the literature (2015–2020) (2022)
Ona, Genís; Rocha, Juliana Mendes; Bouso, José Carlos; Hallak, Jaime Eduardo Cecilio ; Borràs, Tre; Colomina, Maria Teresa; Santos, Rafael Guimarães dos
Fonte: Psychopharmacology. Unidade: FMRP
Assuntos: ALCALOIDES, ALUCINOGÊNICOS, USO DE MEDICAMENTOS, INTERAÇÃO ENTRE ALIMENTOS E MEDICAMENTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ONA, Genís et al. The adverse events of ibogaine in humans: an updated systematic review of the literature (2015–2020). Psychopharmacology, v. 239, n. 6, p. 1977-1987, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00213-021-05964-y. Acesso em: 22 nov. 2025.
APA
Ona, G., Rocha, J. M., Bouso, J. C., Hallak, J. E. C., Borràs, T., Colomina, M. T., & Santos, R. G. dos. (2022). The adverse events of ibogaine in humans: an updated systematic review of the literature (2015–2020). Psychopharmacology, 239( 6), 1977-1987. doi:10.1007/s00213-021-05964-y
NLM
Ona G, Rocha JM, Bouso JC, Hallak JEC, Borràs T, Colomina MT, Santos RG dos. The adverse events of ibogaine in humans: an updated systematic review of the literature (2015–2020) [Internet]. Psychopharmacology. 2022 ; 239( 6): 1977-1987.[citado 2025 nov. 22 ] Available from: https://doi.org/10.1007/s00213-021-05964-y
Vancouver
Ona G, Rocha JM, Bouso JC, Hallak JEC, Borràs T, Colomina MT, Santos RG dos. The adverse events of ibogaine in humans: an updated systematic review of the literature (2015–2020) [Internet]. Psychopharmacology. 2022 ; 239( 6): 1977-1987.[citado 2025 nov. 22 ] Available from: https://doi.org/10.1007/s00213-021-05964-y
Artigo de periodico-carta/editorial
Adverse effects after Ayahuasca administration in the clinical setting [Carta] (2022)
Rocha, Juliana Mendes; Rossi, Giordano Novak; Osório, Flávia de Lima ; Hallak, Jaime Eduardo Cecilio ; Santos, Rafael Guimarães dos
Fonte: Journal of Clinical Psychopharmacology. Unidade: FMRP
Assuntos: FÁRMACOS (SISTEMA NERVOSO CENTRAL), PLANTAS ALUCINÓGENAS, ALUCINOGÊNICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, Juliana Mendes et al. Adverse effects after Ayahuasca administration in the clinical setting [Carta]. Journal of Clinical Psychopharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1097/JCP.0000000000001536. Acesso em: 22 nov. 2025. , 2022
APA
Rocha, J. M., Rossi, G. N., Osório, F. de L., Hallak, J. E. C., & Santos, R. G. dos. (2022). Adverse effects after Ayahuasca administration in the clinical setting [Carta]. Journal of Clinical Psychopharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1097/JCP.0000000000001536
NLM
Rocha JM, Rossi GN, Osório F de L, Hallak JEC, Santos RG dos. Adverse effects after Ayahuasca administration in the clinical setting [Carta] [Internet]. Journal of Clinical Psychopharmacology. 2022 ; 42( 3): 321-324.[citado 2025 nov. 22 ] Available from: https://doi.org/10.1097/JCP.0000000000001536
Vancouver
Rocha JM, Rossi GN, Osório F de L, Hallak JEC, Santos RG dos. Adverse effects after Ayahuasca administration in the clinical setting [Carta] [Internet]. Journal of Clinical Psychopharmacology. 2022 ; 42( 3): 321-324.[citado 2025 nov. 22 ] Available from: https://doi.org/10.1097/JCP.0000000000001536
Artigo de periodico
Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016–2020) systematic review of preclinical and human studies (2022)
Rodrigues, Lucas Silva; Rossi, Giordano Novak ; Rocha, Juliana Mendes; Osório, Flávia de Lima ; Bouso, José Carlos; Hallak, Jaime Eduardo Cecilio ; Santos, Rafael Guimarães dos
Fonte: European Archives of Psychiatry and Clinical Neuroscience. Unidade: FMRP
Assuntos: TRANSTORNOS RELACIONADOS AO USO DE SUBSTÂNCIAS, ALUCINOGÊNICOS, DROGAS DE ABUSO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Lucas Silva et al. Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016–2020) systematic review of preclinical and human studies. European Archives of Psychiatry and Clinical Neuroscience, v. 272, n. 4, p. 541-556, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00406-021-01267-7. Acesso em: 22 nov. 2025.
APA
Rodrigues, L. S., Rossi, G. N., Rocha, J. M., Osório, F. de L., Bouso, J. C., Hallak, J. E. C., & Santos, R. G. dos. (2022). Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016–2020) systematic review of preclinical and human studies. European Archives of Psychiatry and Clinical Neuroscience, 272( 4), 541-556. doi:10.1007/s00406-021-01267-7
NLM
Rodrigues LS, Rossi GN, Rocha JM, Osório F de L, Bouso JC, Hallak JEC, Santos RG dos. Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016–2020) systematic review of preclinical and human studies [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2022 ; 272( 4): 541-556.[citado 2025 nov. 22 ] Available from: https://doi.org/10.1007/s00406-021-01267-7
Vancouver
Rodrigues LS, Rossi GN, Rocha JM, Osório F de L, Bouso JC, Hallak JEC, Santos RG dos. Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016–2020) systematic review of preclinical and human studies [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2022 ; 272( 4): 541-556.[citado 2025 nov. 22 ] Available from: https://doi.org/10.1007/s00406-021-01267-7
Artigo de periodico
Molecular pathways of the therapeutic effects of Ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant (2022)
Rossi, Giordano Novak; Guerra, Lorena Terene Lopes; Baker, Glen B.; Dursun, Serdar M.; Saiz, José Carlos Bouso; Hallak, Jaime Eduardo Cecilio ; Santos, Rafael Guimarães dos
Fonte: Biomolecules. Unidade: FMRP
Assuntos: ALCALOIDES, ANTIDEPRESSIVOS, ALUCINOGÊNICOS, PLANTAS ALUCINÓGENAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROSSI, Giordano Novak et al. Molecular pathways of the therapeutic effects of Ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant. Biomolecules, v. 12, n. 11, p. 1-24, 2022Tradução . . Disponível em: https://doi.org/10.3390/biom12111618. Acesso em: 22 nov. 2025.
APA
Rossi, G. N., Guerra, L. T. L., Baker, G. B., Dursun, S. M., Saiz, J. C. B., Hallak, J. E. C., & Santos, R. G. dos. (2022). Molecular pathways of the therapeutic effects of Ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant. Biomolecules, 12( 11), 1-24. doi:10.3390/biom12111618
NLM
Rossi GN, Guerra LTL, Baker GB, Dursun SM, Saiz JCB, Hallak JEC, Santos RG dos. Molecular pathways of the therapeutic effects of Ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant [Internet]. Biomolecules. 2022 ; 12( 11): 1-24.[citado 2025 nov. 22 ] Available from: https://doi.org/10.3390/biom12111618
Vancouver
Rossi GN, Guerra LTL, Baker GB, Dursun SM, Saiz JCB, Hallak JEC, Santos RG dos. Molecular pathways of the therapeutic effects of Ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant [Internet]. Biomolecules. 2022 ; 12( 11): 1-24.[citado 2025 nov. 22 ] Available from: https://doi.org/10.3390/biom12111618
Artigo de periodico
Mitochondrial photobiomodulation as a neurotherapeutic strategy for epilepsy (2022)
Cardoso, Fabrízio dos Santos; Gonzalez-Lima, Francisco; Coimbra, Norberto Cysne
Fonte: Frontiers in Neurology. Unidade: FMRP
Assuntos: EPILEPSIA, TERAPIA A LASER, MITOCÔNDRIAS, ESTRESSE OXIDATIVO, CONVULSÕES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARDOSO, Fabrízio dos Santos e GONZALEZ-LIMA, Francisco e COIMBRA, Norberto Cysne. Mitochondrial photobiomodulation as a neurotherapeutic strategy for epilepsy. Frontiers in Neurology, v. 13, p. 1-5, 2022Tradução . . Disponível em: https://doi.org/10.3389/fneur.2022.873496. Acesso em: 22 nov. 2025.
APA
Cardoso, F. dos S., Gonzalez-Lima, F., & Coimbra, N. C. (2022). Mitochondrial photobiomodulation as a neurotherapeutic strategy for epilepsy. Frontiers in Neurology, 13, 1-5. doi:10.3389/fneur.2022.873496
NLM
Cardoso F dos S, Gonzalez-Lima F, Coimbra NC. Mitochondrial photobiomodulation as a neurotherapeutic strategy for epilepsy [Internet]. Frontiers in Neurology. 2022 ; 13 1-5.[citado 2025 nov. 22 ] Available from: https://doi.org/10.3389/fneur.2022.873496
Vancouver
Cardoso F dos S, Gonzalez-Lima F, Coimbra NC. Mitochondrial photobiomodulation as a neurotherapeutic strategy for epilepsy [Internet]. Frontiers in Neurology. 2022 ; 13 1-5.[citado 2025 nov. 22 ] Available from: https://doi.org/10.3389/fneur.2022.873496
Artigo de periodico
Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study (2021)
Gaya, Carolina de Meneses; Crippa, José Alexandre de Souza ; Hallak, Jaime Eduardo Cecilio ; Miguel, André Q.; Laranjeira, Ronaldo; Bressan, Rodrigo Affonseca; Zuardi, Antonio Waldo; Lacerda, Acioly Luiz Tavares
Fonte: Brazilian Journal of Psychiatry. Unidade: FMRP
Assuntos: COCAÍNA, CANABINOIDES, TRANSTORNOS RELACIONADOS AO USO DE SUBSTÂNCIAS, DEPENDENTES QUÍMICOS, MÉTODO DUPLO-CEGO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GAYA, Carolina de Meneses et al. Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study. Brazilian Journal of Psychiatry, v. 43, n. 5 , p. 467-476, 2021Tradução . . Disponível em: https://doi.org/10.1590/1516-4446-2020-1416. Acesso em: 22 nov. 2025.
APA
Gaya, C. de M., Crippa, J. A. de S., Hallak, J. E. C., Miguel, A. Q., Laranjeira, R., Bressan, R. A., et al. (2021). Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study. Brazilian Journal of Psychiatry, 43( 5 ), 467-476. doi:10.1590/1516-4446-2020-1416
NLM
Gaya C de M, Crippa JA de S, Hallak JEC, Miguel AQ, Laranjeira R, Bressan RA, Zuardi AW, Lacerda ALT. Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study [Internet]. Brazilian Journal of Psychiatry. 2021 ; 43( 5 ): 467-476.[citado 2025 nov. 22 ] Available from: https://doi.org/10.1590/1516-4446-2020-1416
Vancouver
Gaya C de M, Crippa JA de S, Hallak JEC, Miguel AQ, Laranjeira R, Bressan RA, Zuardi AW, Lacerda ALT. Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study [Internet]. Brazilian Journal of Psychiatry. 2021 ; 43( 5 ): 467-476.[citado 2025 nov. 22 ] Available from: https://doi.org/10.1590/1516-4446-2020-1416
Artigo de periodico
Chemogenetic modulation of sensory neurons reveals their regulating role in melanoma progression (2021)
Costa, Pedro A. C.; Silva, Walison N.; Prazeres, Pedro H. D. M.; Picoli, Caroline C.; Guardia, Gabriela D. A.; Costa, Alinne C.; Oliveira, Mariana A.; Guimarães, Pedro P. G.; Goncalves, Ricardo; Pinto, Mauro C. X.; Amorim, Jaime H.; Azevedo, Vasco A. C.; Resende, Rodrigo R.; Russo, Remo C.; Cunha, Thiago Mattar; Galante, Pedro Alexandre Favoretto; Mintz, Akiva; Birbrair, Alexander
Fonte: Acta Neuropathologica Communications. Unidades: FMRP, Interunidades em Bioinformática, FMVZ
Assuntos: COMPORTAMENTO ANIMAL, BIÓPSIA, LINHAGEM CELULAR, LINFÓCITOS, MELANOMA, NEOVASCULARIZAÇÃO PATOLÓGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Pedro A. C. et al. Chemogenetic modulation of sensory neurons reveals their regulating role in melanoma progression. Acta Neuropathologica Communications, v. 9, 2021Tradução . . Disponível em: https://doi.org/10.1186/s40478-021-01273-9. Acesso em: 22 nov. 2025.
APA
Costa, P. A. C., Silva, W. N., Prazeres, P. H. D. M., Picoli, C. C., Guardia, G. D. A., Costa, A. C., et al. (2021). Chemogenetic modulation of sensory neurons reveals their regulating role in melanoma progression. Acta Neuropathologica Communications, 9. doi:10.1186/s40478-021-01273-9
NLM
Costa PAC, Silva WN, Prazeres PHDM, Picoli CC, Guardia GDA, Costa AC, Oliveira MA, Guimarães PPG, Goncalves R, Pinto MCX, Amorim JH, Azevedo VAC, Resende RR, Russo RC, Cunha TM, Galante PAF, Mintz A, Birbrair A. Chemogenetic modulation of sensory neurons reveals their regulating role in melanoma progression [Internet]. Acta Neuropathologica Communications. 2021 ; 9[citado 2025 nov. 22 ] Available from: https://doi.org/10.1186/s40478-021-01273-9
Vancouver
Costa PAC, Silva WN, Prazeres PHDM, Picoli CC, Guardia GDA, Costa AC, Oliveira MA, Guimarães PPG, Goncalves R, Pinto MCX, Amorim JH, Azevedo VAC, Resende RR, Russo RC, Cunha TM, Galante PAF, Mintz A, Birbrair A. Chemogenetic modulation of sensory neurons reveals their regulating role in melanoma progression [Internet]. Acta Neuropathologica Communications. 2021 ; 9[citado 2025 nov. 22 ] Available from: https://doi.org/10.1186/s40478-021-01273-9
Artigo de periodico
Assessment of the hypoglycemic effect of Bixin in alloxan-induced diabetic rats: in vivo and in silico studies (2021)
Keita, Hady; Santos, Cleydson Breno Rodrigues dos ; Ramos, Matheus Mercês; Padilha, Elias Carvalho; Serafim, Rodolfo Bortolozo ; Castro, Andres Navarrete; Amado, Jesus Rafael Rodriguez; Silva, Gabriel Monteiro da ; Ferreira, Irlon Maciel ; Giuliatti, Silvana ; Carvalho, José Carlos Tavares
Fonte: Journal of Biomolecular Structure and Dynamics. Unidade: FMRP
Assuntos: HIPOGLICEMIA, CAROTENOIDES, DIABETES MELLITUS, QUIMIOTERAPIA, FÁRMACOS IMUNOSSUPRESSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KEITA, Hady et al. Assessment of the hypoglycemic effect of Bixin in alloxan-induced diabetic rats: in vivo and in silico studies. Journal of Biomolecular Structure and Dynamics, v. 39, n. 3, p. 1017-1028, 2021Tradução . . Disponível em: https://doi.org/10.1080/07391102.2020.1724567. Acesso em: 22 nov. 2025.
APA
Keita, H., Santos, C. B. R. dos, Ramos, M. M., Padilha, E. C., Serafim, R. B., Castro, A. N., et al. (2021). Assessment of the hypoglycemic effect of Bixin in alloxan-induced diabetic rats: in vivo and in silico studies. Journal of Biomolecular Structure and Dynamics, 39( 3), 1017-1028. doi:10.1080/07391102.2020.1724567
NLM
Keita H, Santos CBR dos, Ramos MM, Padilha EC, Serafim RB, Castro AN, Amado JRR, Silva GM da, Ferreira IM, Giuliatti S, Carvalho JCT. Assessment of the hypoglycemic effect of Bixin in alloxan-induced diabetic rats: in vivo and in silico studies [Internet]. Journal of Biomolecular Structure and Dynamics. 2021 ; 39( 3): 1017-1028.[citado 2025 nov. 22 ] Available from: https://doi.org/10.1080/07391102.2020.1724567
Vancouver
Keita H, Santos CBR dos, Ramos MM, Padilha EC, Serafim RB, Castro AN, Amado JRR, Silva GM da, Ferreira IM, Giuliatti S, Carvalho JCT. Assessment of the hypoglycemic effect of Bixin in alloxan-induced diabetic rats: in vivo and in silico studies [Internet]. Journal of Biomolecular Structure and Dynamics. 2021 ; 39( 3): 1017-1028.[citado 2025 nov. 22 ] Available from: https://doi.org/10.1080/07391102.2020.1724567
Artigo de periodico
Maternal history of childhood violence in the context of a parenting program (2021)
Altafim, Elisa Rachel Pisani ; Oliveira, Rebeca Cristina de ; Linhares, Maria Beatriz Martins
Fonte: Journal of Child and Family Studies. Unidades: FMRP, FFCLRP
Assuntos: VIOLÊNCIA CONTRA O MENOR, PARENTALIDADE, MAUS-TRATOS INFANTIS, BEM-ESTAR DA CRIANÇA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALTAFIM, Elisa Rachel Pisani e OLIVEIRA, Rebeca Cristina de e LINHARES, Maria Beatriz Martins. Maternal history of childhood violence in the context of a parenting program. Journal of Child and Family Studies, v. 30, n. 1, p. 230-242, 2021Tradução . . Disponível em: https://doi.org/10.1007/s10826-020-01868-1. Acesso em: 22 nov. 2025.
APA
Altafim, E. R. P., Oliveira, R. C. de, & Linhares, M. B. M. (2021). Maternal history of childhood violence in the context of a parenting program. Journal of Child and Family Studies, 30( 1), 230-242. doi:10.1007/s10826-020-01868-1
NLM
Altafim ERP, Oliveira RC de, Linhares MBM. Maternal history of childhood violence in the context of a parenting program [Internet]. Journal of Child and Family Studies. 2021 ; 30( 1): 230-242.[citado 2025 nov. 22 ] Available from: https://doi.org/10.1007/s10826-020-01868-1
Vancouver
Altafim ERP, Oliveira RC de, Linhares MBM. Maternal history of childhood violence in the context of a parenting program [Internet]. Journal of Child and Family Studies. 2021 ; 30( 1): 230-242.[citado 2025 nov. 22 ] Available from: https://doi.org/10.1007/s10826-020-01868-1
Artigo de periodico
Effects of ayahuasca on personality: results of two randomized, placebo-controlled trials in healthy volunteers (2021)
Rocha, Juliana Mendes; Rossi, Giordano Novak ; Osório, Flávia de Lima ; Saiz, José Carlos Bouso; Silveira, Gabriela de Oliveira; Yonamine, Maurício ; Crevelin, Eduardo José ; Queiroz, Maria Eugênia Costa ; Hallak, Jaime Eduardo Cecilio ; Santos, Rafael Guimarães dos
Fonte: Frontiers in Psychiatry. Unidades: FMRP, FCF, FFCLRP
Assuntos: ALUCINOGÊNICOS, PLACEBOS, PERSONALIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, Juliana Mendes et al. Effects of ayahuasca on personality: results of two randomized, placebo-controlled trials in healthy volunteers. Frontiers in Psychiatry, v. 12, p. 1-7 art. 688439, 2021Tradução . . Disponível em: https://doi.org/10.3389/fpsyt.2021.688439. Acesso em: 22 nov. 2025.
APA
Rocha, J. M., Rossi, G. N., Osório, F. de L., Saiz, J. C. B., Silveira, G. de O., Yonamine, M., et al. (2021). Effects of ayahuasca on personality: results of two randomized, placebo-controlled trials in healthy volunteers. Frontiers in Psychiatry, 12, 1-7 art. 688439. doi:10.3389/fpsyt.2021.688439
NLM
Rocha JM, Rossi GN, Osório F de L, Saiz JCB, Silveira G de O, Yonamine M, Crevelin EJ, Queiroz MEC, Hallak JEC, Santos RG dos. Effects of ayahuasca on personality: results of two randomized, placebo-controlled trials in healthy volunteers [Internet]. Frontiers in Psychiatry. 2021 ; 12 1-7 art. 688439.[citado 2025 nov. 22 ] Available from: https://doi.org/10.3389/fpsyt.2021.688439
Vancouver
Rocha JM, Rossi GN, Osório F de L, Saiz JCB, Silveira G de O, Yonamine M, Crevelin EJ, Queiroz MEC, Hallak JEC, Santos RG dos. Effects of ayahuasca on personality: results of two randomized, placebo-controlled trials in healthy volunteers [Internet]. Frontiers in Psychiatry. 2021 ; 12 1-7 art. 688439.[citado 2025 nov. 22 ] Available from: https://doi.org/10.3389/fpsyt.2021.688439
Artigo de periodico
Non-lethal concentration of meHg causes marked responses in the DNA repair, integrity, and replication pathways in the exposed human salivary gland cell line (2021)
Nogueira, Lygia Sega; Vasconcelos, Carolina P.; Plaça, Jessica Rodrigues ; Mitre, Geovanni Pereira; Bittencourt, Leonardo Oliveira; Kataoka, Maria Sueli da Silva ; Oliveira, Edivaldo H. C. de; Lima, Rafael Rodrigues
Fonte: Frontiers in Pharmacology. Unidade: FMRP
Assuntos: BIOMARCADORES, GLÂNDULAS SALIVARES, TOXICOLOGIA, LINHAGEM CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOGUEIRA, Lygia Sega et al. Non-lethal concentration of meHg causes marked responses in the DNA repair, integrity, and replication pathways in the exposed human salivary gland cell line. Frontiers in Pharmacology, v. 12, p. 1-8, 2021Tradução . . Disponível em: https://doi.org/10.3389/fphar.2021.698671. Acesso em: 22 nov. 2025.
APA
Nogueira, L. S., Vasconcelos, C. P., Plaça, J. R., Mitre, G. P., Bittencourt, L. O., Kataoka, M. S. da S., et al. (2021). Non-lethal concentration of meHg causes marked responses in the DNA repair, integrity, and replication pathways in the exposed human salivary gland cell line. Frontiers in Pharmacology, 12, 1-8. doi:10.3389/fphar.2021.698671
NLM
Nogueira LS, Vasconcelos CP, Plaça JR, Mitre GP, Bittencourt LO, Kataoka MS da S, Oliveira EHC de, Lima RR. Non-lethal concentration of meHg causes marked responses in the DNA repair, integrity, and replication pathways in the exposed human salivary gland cell line [Internet]. Frontiers in Pharmacology. 2021 ; 12 1-8.[citado 2025 nov. 22 ] Available from: https://doi.org/10.3389/fphar.2021.698671
Vancouver
Nogueira LS, Vasconcelos CP, Plaça JR, Mitre GP, Bittencourt LO, Kataoka MS da S, Oliveira EHC de, Lima RR. Non-lethal concentration of meHg causes marked responses in the DNA repair, integrity, and replication pathways in the exposed human salivary gland cell line [Internet]. Frontiers in Pharmacology. 2021 ; 12 1-8.[citado 2025 nov. 22 ] Available from: https://doi.org/10.3389/fphar.2021.698671
Artigo de periodico
Ayahuasca improves self-perception of speech performance in subjects with social anxiety disorder: a pilot, proof-of-concept, randomized, placebo-controlled trial (2021)
Santos, Rafael Guimarães dos ; Osório, Flávia de Lima ; Rocha, Juliana Mendes; Rossi, Giordano Novak ; Bouso, José Carlos ; Rodrigues, Lucas Silva; Silveira, Gabriela de Oliveira ; Yonamine, Maurício ; Hallak, Jaime Eduardo Cecilio
Fonte: Journal of Clinical Psychopharmacology. Unidades: FMRP, FCF
Assuntos: ANSIEDADE SOCIAL, ALUCINOGÊNICOS, CHÁ, TRANSTORNOS DA ANSIEDADE, ANSIEDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Rafael Guimarães dos et al. Ayahuasca improves self-perception of speech performance in subjects with social anxiety disorder: a pilot, proof-of-concept, randomized, placebo-controlled trial. Journal of Clinical Psychopharmacology, v. 41, n. 5, p. 540-550, 2021Tradução . . Disponível em: https://doi.org/10.1097/JCP.0000000000001428. Acesso em: 22 nov. 2025.
APA
Santos, R. G. dos, Osório, F. de L., Rocha, J. M., Rossi, G. N., Bouso, J. C., Rodrigues, L. S., et al. (2021). Ayahuasca improves self-perception of speech performance in subjects with social anxiety disorder: a pilot, proof-of-concept, randomized, placebo-controlled trial. Journal of Clinical Psychopharmacology, 41( 5), 540-550. doi:10.1097/JCP.0000000000001428
NLM
Santos RG dos, Osório F de L, Rocha JM, Rossi GN, Bouso JC, Rodrigues LS, Silveira G de O, Yonamine M, Hallak JEC. Ayahuasca improves self-perception of speech performance in subjects with social anxiety disorder: a pilot, proof-of-concept, randomized, placebo-controlled trial [Internet]. Journal of Clinical Psychopharmacology. 2021 ; 41( 5): 540-550.[citado 2025 nov. 22 ] Available from: https://doi.org/10.1097/JCP.0000000000001428
Vancouver
Santos RG dos, Osório F de L, Rocha JM, Rossi GN, Bouso JC, Rodrigues LS, Silveira G de O, Yonamine M, Hallak JEC. Ayahuasca improves self-perception of speech performance in subjects with social anxiety disorder: a pilot, proof-of-concept, randomized, placebo-controlled trial [Internet]. Journal of Clinical Psychopharmacology. 2021 ; 41( 5): 540-550.[citado 2025 nov. 22 ] Available from: https://doi.org/10.1097/JCP.0000000000001428
Artigo de periodico-carta/editorial
Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy [Editorial] (2021)
Santos, Rafael Guimarães dos ; Bouso, José C.; Hallak, Jaime Eduardo Cecilio
Fonte: Brazilian Journal of Psychiatry. Unidade: FMRP
Assuntos: TRANSTORNOS MENTAIS, ALUCINOGÊNICOS, FARMACOLOGIA CLÍNICA, RECEPTORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Rafael Guimarães dos e BOUSO, José C. e HALLAK, Jaime Eduardo Cecilio. Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy [Editorial]. Brazilian Journal of Psychiatry. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1590/1516-4446-2020-1035. Acesso em: 22 nov. 2025. , 2021
APA
Santos, R. G. dos, Bouso, J. C., & Hallak, J. E. C. (2021). Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy [Editorial]. Brazilian Journal of Psychiatry. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1590/1516-4446-2020-1035
NLM
Santos RG dos, Bouso JC, Hallak JEC. Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy [Editorial] [Internet]. Brazilian Journal of Psychiatry. 2021 ; 43( 2): 119-120.[citado 2025 nov. 22 ] Available from: https://doi.org/10.1590/1516-4446-2020-1035
Vancouver
Santos RG dos, Bouso JC, Hallak JEC. Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy [Editorial] [Internet]. Brazilian Journal of Psychiatry. 2021 ; 43( 2): 119-120.[citado 2025 nov. 22 ] Available from: https://doi.org/10.1590/1516-4446-2020-1035
Artigo de periodico
Endocannabinoid neuromodulation in the neostriatum decreases the GABAergic striato-nigral disinhibitory function and increases the nigro-collicular inhibitory pathway activity (2020)
Silva, Juliana Almeida da ; Almada, Rafael Carvalho ; Paiva, Yara Bezerra de ; Coimbra, Norberto Cysne
Fonte: Journal of Neural Transmission. Unidade: FMRP
Assuntos: MEDO, PÂNICO, NEURÔNIOS, CANABINOIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Juliana Almeida da et al. Endocannabinoid neuromodulation in the neostriatum decreases the GABAergic striato-nigral disinhibitory function and increases the nigro-collicular inhibitory pathway activity. Journal of Neural Transmission, v. 127, n. 8, p. 1199-1208, 2020Tradução . . Disponível em: https://doi.org/10.1007/s00702-020-02217-8. Acesso em: 22 nov. 2025.
APA
Silva, J. A. da, Almada, R. C., Paiva, Y. B. de, & Coimbra, N. C. (2020). Endocannabinoid neuromodulation in the neostriatum decreases the GABAergic striato-nigral disinhibitory function and increases the nigro-collicular inhibitory pathway activity. Journal of Neural Transmission, 127( 8), 1199-1208. doi:10.1007/s00702-020-02217-8
NLM
Silva JA da, Almada RC, Paiva YB de, Coimbra NC. Endocannabinoid neuromodulation in the neostriatum decreases the GABAergic striato-nigral disinhibitory function and increases the nigro-collicular inhibitory pathway activity [Internet]. Journal of Neural Transmission. 2020 ; 127( 8): 1199-1208.[citado 2025 nov. 22 ] Available from: https://doi.org/10.1007/s00702-020-02217-8
Vancouver
Silva JA da, Almada RC, Paiva YB de, Coimbra NC. Endocannabinoid neuromodulation in the neostriatum decreases the GABAergic striato-nigral disinhibitory function and increases the nigro-collicular inhibitory pathway activity [Internet]. Journal of Neural Transmission. 2020 ; 127( 8): 1199-1208.[citado 2025 nov. 22 ] Available from: https://doi.org/10.1007/s00702-020-02217-8

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Assuntos

Título da fonte

País de publicação

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos